humoral immunity
Showing 1 - 25 of 2,455
Humoral Immunity Trial in Gomel (Protein subunit vaccine Soberana Plus (FINLAY-FR-1A) is a vaccine against COVID-19 produced by
Enrolling by invitation
- Humoral Immunity
- Protein subunit vaccine Soberana Plus (FINLAY-FR-1A) is a vaccine against COVID-19 produced by The Finlay Vaccine Institute and The Centre of Molecular Immunology (Republic of Cuba)
-
Gomel, BelarusGomel State Medical University
Jan 30, 2023
Evaluation of Humoral Immunity Following COVID-19 in Pregnancy
Active, not recruiting
- COVID-19
- +2 more
- Blood sample
-
London, United Kingdom
- +1 more
Aug 8, 2022
Host Genetic Factors Underlying Ebola Virus Disease Risk,
Completed
- Ebola Virus Disease
-
Kalkata, Liberia
- +3 more
Aug 18, 2022
SARS CoV 2 Infection, COVID-19 Trial in Brussels (Humoral immunity)
Enrolling by invitation
- SARS CoV 2 Infection
- COVID-19
- Humoral immunity
-
Brussels, BelgiumSciensano
Jan 16, 2023
Diffuse Large-Cell Lymphoma, Primary Mediastinal Large B-Cell Lymphoma (PMBCL), Transformed Follicular Lymphoma (TFL) Trial in
Recruiting
- Diffuse Large-Cell Lymphoma
- +3 more
- Pneumococcal conjugate vaccine (PCV13)
- CD19 targeted CAR T Cell Therapy
-
Tampa, FloridaMoffitt Cancer Center
May 31, 2022
COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in
Not yet recruiting
- Follicular Lymphoma
- Cellular immunity vs SARS-CoV-2
- +6 more
-
Alessandria, IT, Italy
- +13 more
Oct 10, 2023
Hepatitis B Trial in Baltimore, Falls Church (Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B])
Withdrawn
- Hepatitis B
- Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B]
-
Baltimore, Maryland
- +1 more
Jul 19, 2022
Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in
Active, not recruiting
- SARS-CoV-2 RNA Vaccines
- HIV Infection
- SARS-CoV-2 Vaccine
-
Sevilla, SpainVirgen del Rocio University Hospital
Dec 1, 2022
COVID-19 Trial in Singapore (Homologous mRNA booster vaccine, Heterologous mRNA booster vaccine, Non-mRNA booster vaccine A)
Recruiting
- COVID-19
- Homologous mRNA booster vaccine
- +4 more
-
Singapore, SingaporeNational Centre for Infectious Diseases (NCID)
Nov 30, 2021
SARS-CoV-2, Safety, Immunotoxicity Trial in Wuhan (one dose of the study SARS-CoV-2 mRNA Vaccine (SYS6006), Cellular Immunity,
Not yet recruiting
- SARS-CoV-2
- +2 more
- one dose of the study SARS-CoV-2 mRNA Vaccine (SYS6006)
- +3 more
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Aug 9, 2022
Humoral and Cellular Immunity in First-cycle SARS-CoV-2
Completed
- SARS CoV 2 Infection
- COVID-19
- LIAISON SARS-CoV-2 TrimericS IgG (DiaSorin)
- +2 more
-
Catanzaro, ItalyAOU Mater Domini
Jul 15, 2022
Dynamics of Humoral and Cellular Immunity in COVID-19 Patients
Completed
- Covid19
- Humoral and cellular immunity
-
Minsk, BelarusInstitute of Biophysics and Cell Engineering of National Academy
Dec 9, 2021
Mumps, Measles, Rubella Trial in Zürich (MMR booster vaccination (as M-M-R-VaxPro))
Not yet recruiting
- Mumps
- +2 more
- MMR booster vaccination (as M-M-R-VaxPro)
-
Zürich, SwitzerlandEpidemiology, Biostatistics and Prevention Institute University
Jun 8, 2023
IgG Subclasses and on Immunity of Secondary Immunodeficiency
Completed
- Secondary Immune Deficiency
- Gammanorm
- Other Subcutaneous Immunoglobulins
-
Chalon-sur-Saône, France
- +5 more
Feb 28, 2022
Poliomyelitis Trial in Dhaka (mOPV1, bOPV, fIPV)
Completed
- Poliomyelitis
- mOPV1
- +2 more
-
Dhaka, Bangladeshicddr,b study clinics (Mirpur and CTU Dhaka)
Feb 18, 2021
Tick Borne Encephalitis Trial in Vienna (TBE virus vaccine)
Completed
- Tick Borne Encephalitis
- TBE virus vaccine
-
Vienna, AustriaMedical University of Vienna, Department of Medicine I, Division
Jan 27, 2022
Tunis Military Hospital Staff Vaccinated Against Covid 19 Trial in Tunis (Blood sampling (4 per year))
Recruiting
- Tunis Military Hospital Staff Vaccinated Against Covid 19
- Blood sampling (4 per year)
-
Tunis, Please Select..., TunisiaHMPIT vaccination committee
Jun 10, 2021
Pneumococcal Infections Trial in Helsinki (10-valent pneumococcal conjugate vaccine, PCV10)
Completed
- Pneumococcal Infections
- 10-valent pneumococcal conjugate vaccine, PCV10
-
Helsinki, FinlandFinnish Institute for Health and Welfare
Aug 10, 2021
Kidney Transplantation, Graft Rejection, Humoral Immunity Trial in Bordeaux, Lyon, Paris (Mass spectrometry-based proteomics of
Recruiting
- Kidney Transplantation
- +3 more
- Mass spectrometry-based proteomics of FFPE biopsies and urine samples
-
Bordeaux, France
- +2 more
Nov 8, 2021
Health Status of Children Born After Assisted Reproductive
Recruiting
- Children Born After Assisted Reproductive Technologies
- +2 more
- hemogram examination
-
Almaty, KazakhstanSevara ilmuratova
Oct 17, 2023
Covid19 Trial in Augsburg (duplex sonography)
Completed
- Covid19
- duplex sonography
-
Augsburg, GermanyUniversity Hospital Augsburg
May 30, 2022
Cellular and Humoral Immunity to COVID-19 in Moscow Residents
Recruiting
- Covid19
- Respiratory Viral Infection
- SARS-CoV-2 specific IgM and IgG detection
- +2 more
-
Moscow, Russian FederationClinical City Hospital named after I.V. Davydovsky of Moscow Dep
May 21, 2021
Aspergillosis and Humoral Alveolar Immunity by Proteomics
Unknown status
- Aspergillus Fumigatus Infection
- Protein profile
- (no location specified)
Jan 24, 2021
Acne Vulgaris Related Microbiology and Serology
Completed
- Acne Vulgaris
- Study of humoral immunity
-
Norfolk, VirginiaClinical Research Associates of Tidewater
Jan 5, 2021